COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors

Shukla Shakti D.; Walters E. Haydn

首页> 外文期刊>Internal medicine journal >COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors

【24h】

COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors

机译：Covid-19和慢性阻塞性肺病：阻断SARS-COV2粘附因子的治疗潜力

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Internal medicine journal》 |2020年第9期|共2页
作者
Shukla Shakti D.; Walters E. Haydn;
展开▼
作者单位

Univ Newcastle Sch Med &

Publ Hlth Fac Hlth &

Med Newcastle NSW Australia;

Univ Tasmania Coll Hlth &

Med Hobart Tas Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Sialic acid-binding immunoglobulin-like lectin 9 as a potential therapeutic target for chronic obstructive pulmonary disease [J] . Zi Chen, Shuang-Lan Xu, Lin-Yang Ge, 中华医学杂志（英文版） . 2021,第007期
2. Renewed vision on pulmonary rehabilitation service delivery for chronic obstructive pulmonary disease management beyond COVID-19 [J] . Shakila Devi Perumal 慢性疾病与转化医学（英文） . 2021,第002期
3. Renewed vision on pulmonary rehabilitation service delivery for chronic obstructive pulmonary disease management beyond COVID-19 [J] . Shakila Devi Perumal 慢性疾病与转化医学：英文版 . 2021,第002期
4. Effects of terbutaline combined with methylprednisolone on pulmonary function, blood gas analysis and inflammatory factors in patients with chronic obstructive pulmonary disease [J] . Jin-Jin Cheng, Hong-Rong Guo, Bo Huang, 海南医科大学学报（英文版） . 2017,第024期
5. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease. [J] . Woodside DG, Vanderslice P BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy . 2008,第2期

机译：细胞粘附拮抗剂：在哮喘和慢性阻塞性肺疾病中具有治疗潜力。
6. Platelet activating factor receptor: gateway for bacterial chronic airway infection in chronic obstructive pulmonary disease and potential therapeutic target [J] . Shukla Shakti Dhar, Sohal Sukhwinder Singh, OToole Ronan F., Expert review of respiratory medicine . 2015,第4期

机译：血小板活化因子受体：慢性阻塞性肺疾病中细菌性慢性气道感染的途径和潜在的治疗靶标
7. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). [J] . Vlahos R, Bozinovski S, Hamilton JA, Pharmacology and Therapeutics: The Journal of the International Encyclopedia of Pharmacology and Therapeutics . 2006,第1期

机译：通过中和粒细胞巨噬细胞集落刺激因子（GM-CSF）治疗慢性阻塞性肺疾病（COPD）的治疗潜力。
8. Exploiting the Relation Between Environmental Factors and Diseases: A Case Study on Chronic Obstructive Pulmonary Disease [C] . David Riano, Agusti Solanas Knowledge representation for health-care . 2014

机译：探索环境因素与疾病的关系：以慢性阻塞性肺疾病为例
9. The influence of physiological factors, psychological factors, and informal social support on hospital readmission in discharged patients with chronic obstructive pulmonary disease (COPD) in Taiwan. [D] . Chen, Yea-Jyh. 2005

机译：台湾地区慢性阻塞性肺疾病（COPD）出院患者的生理因素，心理因素和非正式的社会支持对住院率的影响。
10. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study [O] . Yaa-Hui Dong, Matthew Alcusky, Vittorio Maio, 2017

机译：慢性阻塞性肺疾病和急性冠状动脉综合征患者中β受体阻滞剂和钙通道阻滞剂比较的潜在偏倚证据：一项跨国研究的结果
11. COVID ‐19 and c hronic obstructive pulmonary disease : therapeutic potential of blocking SARS‐CoV2 adhesion factors [O] . Shakti D. Shukla, E. Haydn Walters 2020

机译：Covid -19和C慢性阻塞性肺病：阻断SARS-COV 2粘附因子的治疗潜力
12. Risk Factors in COPD (Chronic Obstructive Pulmonary Disease) in an Upper Midwest Rural Community, Rochester, and Southeastern Minnesota. [R] . Miller, R. D. 1976

机译：中西部农村社区，罗切斯特和明尼苏达州东南部COpD（慢性阻塞性肺病）的危险因素。

COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors

著录项

相似文献

相关主题

期刊订阅